RTOG 1016: Cisplatin Still Standard for HPV-Related Oral Cancer RTOG 1016: Cisplatin Still Standard for HPV-Related Oral Cancer
Cisplatin plus radiation therapy was superior to cetuximab/radiation therapy for all endpoints, but toxicity burden is much higherMedscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Erbitux | Health | Hematology | Oral Cancer | Radiation Therapy | Toxicology